Sign up for updates
If you are interested in participating or learning about future trials, then please complete the form on our contact page or contact the team at firstname.lastname@example.org.
For sales enquiries and trials outside Auckland
For all other trials and sales enquiries please contact the team at email@example.com.
For all media enquires please contact the team at firstname.lastname@example.org with your contact details and request. Images and video of the Axon product are available upon request.
Exsurgo announces John Emson as new CFO
Exsurgo has appointed experienced financial executive John Emson as its first Chief Financial Officer. Emson, who has spent over 30 years in finance and M&A across the technology, manufacturing, h…READ
May 7, 2021
Exsurgo CTO Faisal Almesfer co-authors paper on stroke rehabilitation
Background: As many as 80% of stroke survivors experience upper limb (UL) disability. The strong relationships between disability, lost productivity, and ongoing healthcare costs mean reducing disabil…READ
June 17, 2020
Exsurgo announces UK clinical trial to transform the future of chronic pain management
Exsurgo has begun a potentially ground-breaking UK-based clinical trial to determine the effectiveness of Axon, a user-friendly neurofeedback product that treats the primary and secondary symptoms of …READ
June 15, 2020